Marwan Sheikh‐Taha

802 total citations
32 papers, 587 citations indexed

About

Marwan Sheikh‐Taha is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and Internal Medicine. According to data from OpenAlex, Marwan Sheikh‐Taha has authored 32 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 9 papers in Genetics and 9 papers in Internal Medicine. Recurrent topics in Marwan Sheikh‐Taha's work include Atrial Fibrillation Management and Outcomes (9 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Hemoglobinopathies and Related Disorders (8 papers). Marwan Sheikh‐Taha is often cited by papers focused on Atrial Fibrillation Management and Outcomes (9 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Hemoglobinopathies and Related Disorders (8 papers). Marwan Sheikh‐Taha collaborates with scholars based in Lebanon, United States and United Kingdom. Marwan Sheikh‐Taha's co-authors include Alì Taher, Fadi H. Mourad, Hani Dimassi, Adlette Inati, A. V. Hoffbrand, Lourdes C. Corman, Suzanne Koussa, Ala I. Sharara, Elie Aoun and John C. Wood and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of the American College of Cardiology.

In The Last Decade

Marwan Sheikh‐Taha

31 papers receiving 563 citations

Peers

Marwan Sheikh‐Taha
Sumeet Panjabi United States
Yukio Suga Japan
Greg Carney Canada
Elisabeth Bronder Germany
Ylenia Ingrasciotta Italy
Franca Heiman Italy
David Jupe Australia
Erika Prinz Austria
S. Mueller Germany
Ejler Ejlersen Denmark
Sumeet Panjabi United States
Marwan Sheikh‐Taha
Citations per year, relative to Marwan Sheikh‐Taha Marwan Sheikh‐Taha (= 1×) peers Sumeet Panjabi

Countries citing papers authored by Marwan Sheikh‐Taha

Since Specialization
Citations

This map shows the geographic impact of Marwan Sheikh‐Taha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marwan Sheikh‐Taha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marwan Sheikh‐Taha more than expected).

Fields of papers citing papers by Marwan Sheikh‐Taha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marwan Sheikh‐Taha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marwan Sheikh‐Taha. The network helps show where Marwan Sheikh‐Taha may publish in the future.

Co-authorship network of co-authors of Marwan Sheikh‐Taha

This figure shows the co-authorship network connecting the top 25 collaborators of Marwan Sheikh‐Taha. A scholar is included among the top collaborators of Marwan Sheikh‐Taha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marwan Sheikh‐Taha. Marwan Sheikh‐Taha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheikh‐Taha, Marwan. (2024). The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure. American Journal of Cardiovascular Drugs. 24(5). 685–691.
2.
3.
Sheikh‐Taha, Marwan, et al.. (2022). Efficacy and safety of activated prothrombin complex concentrate for the reversal of vitamin K antagonist major bleeding. Scientific Reports. 12(1). 1814–1814. 1 indexed citations
4.
Sheikh‐Taha, Marwan, et al.. (2021). Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States. BMC Geriatrics. 21(1). 233–233. 61 indexed citations
5.
Sheikh‐Taha, Marwan. (2019). Non-activated prothrombin complex concentrates for major bleeding in patients on apixaban and rivaroxaban. Internal and Emergency Medicine. 15(6). 1123–1124. 3 indexed citations
6.
Sheikh‐Taha, Marwan, et al.. (2019). Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding. American Journal of Cardiovascular Drugs. 20(3). 295–299. 9 indexed citations
7.
Sheikh‐Taha, Marwan. (2018). Treatment of apixaban- and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate. Internal and Emergency Medicine. 14(2). 265–269. 37 indexed citations
8.
Sheikh‐Taha, Marwan. (2018). Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience. American Journal of Cardiovascular Drugs. 19(1). 59–64. 19 indexed citations
9.
Sheikh‐Taha, Marwan & Hani Dimassi. (2018). Use of over the counter products in older cardiovascular patients admitted to a tertiary care center in USA. BMC Geriatrics. 18(1). 301–301. 8 indexed citations
10.
Sheikh‐Taha, Marwan & Hani Dimassi. (2017). Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA. BMC Cardiovascular Disorders. 17(1). 189–189. 41 indexed citations
11.
Sheikh‐Taha, Marwan & Hani Dimassi. (2017). POTENTIALLY INAPPROPRIATE HOME MEDICATIONS AMONG OLDER PATIENTS WITH CARDIOVASCULAR DISEASE ADMITTED TO A CARDIOLOGY SERVICE IN USA. Journal of the American College of Cardiology. 69(11). 1758–1758. 2 indexed citations
12.
Sheikh‐Taha, Marwan, et al.. (2016). Prescription patterns of benzodiazepines in the Lebanese adult population: a cross-sectional study. Neuropsychiatric Disease and Treatment. Volume 12. 2299–2305. 12 indexed citations
13.
14.
Sheikh‐Taha, Marwan, et al.. (2012). Use of acid suppressive therapy in hospitalized non-critically ill patients. World Journal of Gastrointestinal Pharmacology and Therapeutics. 3(6). 93–93. 19 indexed citations
15.
Sheikh‐Taha, Marwan, et al.. (2009). Use of deep vein thrombosis prophylaxis in hospitalized cancer patients. Blood Coagulation & Fibrinolysis. 20(7). 571–574. 3 indexed citations
16.
Inati, Adlette, Khaled M. Musallam, John C. Wood, et al.. (2009). Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease. European Journal Of Haematology. 83(6). 565–571. 29 indexed citations
17.
Sheikh‐Taha, Marwan, et al.. (2009). Possible montelukast-induced angioedema. American Journal of Health-System Pharmacy. 66(19). 1705–1706. 8 indexed citations
18.
Sheikh‐Taha, Marwan, et al.. (2007). Febrile Neutropenia and Hemorrhagic Stroke in a Thalassemia Major Patient. Hemoglobin. 31(4). 499–501. 3 indexed citations
19.
Inati, Adlette, Alì Taher, Suzanne Koussa, et al.. (2005). Efficacy and tolerability of peginterferon alpha‐2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection. British Journal of Haematology. 130(4). 644–646. 47 indexed citations
20.
Taher, Alì, Marwan Sheikh‐Taha, Ala I. Sharara, et al.. (2005). Safety and Effectiveness of 100 mg/kg/day Deferiprone in Patients with Thalassemia Major: A Two-Year Study. Acta Haematologica. 114(3). 146–149. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumeet Panjabi Breakdown of academic impact, for papers by Yukio Suga Breakdown of academic impact, for papers by Greg Carney Breakdown of academic impact, for papers by Elisabeth Bronder Breakdown of academic impact, for papers by Ylenia Ingrasciotta Breakdown of academic impact, for papers by Franca Heiman Breakdown of academic impact, for papers by David Jupe Breakdown of academic impact, for papers by Erika Prinz Breakdown of academic impact, for papers by S. Mueller Breakdown of academic impact, for papers by Ejler Ejlersen
Rankless by CCL
2026